These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Significance of plasma creatine and neurologic disorders for the creatine level of cerebrospinal fluid in man]. Berlet HH; Pilz H Z Neurol; 1972; 201(4):310-25. PubMed ID: 4113366 [No Abstract] [Full Text] [Related]
23. Determination of acetylcholine concentration in cerebrospinal fluid of patients with neurologic diseases. Yamada H; Otsuka M; Fujimoto K; Kawashima K; Yoshida M Acta Neurol Scand; 1996 Jan; 93(1):76-8. PubMed ID: 8825278 [TBL] [Abstract][Full Text] [Related]
24. [Calcitonin level in cerebrospinal fluid of patients with amyotrophic lateral sclerosis]. Klimek A; Stepień H; Szulc-Kuberska J; Pisarek H Pol Tyg Lek; 1992 Apr 6-13; 47(14-15):310-1. PubMed ID: 1437739 [TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid levels of biotin in various neurological disorders. Anagnostouli M; Livaniou E; Nyalala JO; Evangelatos G; Zournas C; Ithakissios DS; Papageorgiou C Acta Neurol Scand; 1999 Jun; 99(6):387-92. PubMed ID: 10577274 [TBL] [Abstract][Full Text] [Related]
26. The CSF iron in patients with neurological diseases. Kjellin KG Acta Neurol Scand; 1967; 43(3):299-313. PubMed ID: 4227818 [No Abstract] [Full Text] [Related]
27. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis. Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446 [TBL] [Abstract][Full Text] [Related]
30. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis. Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013 [TBL] [Abstract][Full Text] [Related]
31. High accuracy (stable isotope dilution) measurements of lead in serum and cerebrospinal fluid. Manton WI; Cook JD Br J Ind Med; 1984 Aug; 41(3):313-9. PubMed ID: 6378251 [TBL] [Abstract][Full Text] [Related]
32. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis. Iłzecka J Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840 [TBL] [Abstract][Full Text] [Related]
33. Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3. Yamamoto-Watanabe Y; Watanabe M; Jackson M; Akimoto H; Sugimoto K; Yasujima M; Wakasaya Y; Matsubara E; Kawarabayashi T; Harigaya Y; Lyndon AR; Shoji M Brain Res; 2010 Nov; 1361():140-5. PubMed ID: 20849835 [TBL] [Abstract][Full Text] [Related]
34. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Kaufmann E; Boehm BO; Süssmuth SD; Kientsch-Engel R; Sperfeld A; Ludolph AC; Tumani H Neurosci Lett; 2004 Nov; 371(2-3):226-9. PubMed ID: 15519762 [TBL] [Abstract][Full Text] [Related]
35. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis. Weydt P; Oeckl P; Huss A; Müller K; Volk AE; Kuhle J; Knehr A; Andersen PM; Prudlo J; Steinacker P; Weishaupt JH; Ludolph AC; Otto M Ann Neurol; 2016 Jan; 79(1):152-8. PubMed ID: 26528863 [TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis. Nociti V; Frisullo G; Marti A; Luigetti M; Iorio R; Patanella AK; Bianco A; Tonali PA; Grillo RL; Sabatelli M; Batocchi AP J Neuroimmunol; 2010 Aug; 225(1-2):149-52. PubMed ID: 20510468 [TBL] [Abstract][Full Text] [Related]
38. Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Benninger F; Glat MJ; Offen D; Steiner I J Clin Neurosci; 2016 Apr; 26():75-8. PubMed ID: 26602604 [TBL] [Abstract][Full Text] [Related]
39. Interleukin-12 and interferon-gamma are not detectable in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Ford L; Rowe D Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):118-20. PubMed ID: 15204013 [TBL] [Abstract][Full Text] [Related]
40. Brain-derived neurotrophic factor is not altered in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients. Iłzecka J; Stelmasiak Z Neurol Sci; 2002 Mar; 22(6):473-4. PubMed ID: 11976981 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]